Università degli Studi di Parma
Dipartimento Farmaceutico

Laboratory of Permeation, Transdermal Systems and Iontophoresis


Home Page
The Research Group
Research Subjects

Publications
Patents
Conference Communications

The capabilities of the lab
Collaboration opportunities

Pharmacy Department
Faculty of Pharmacy
University of Parma
How to reach us
Publications
  • In vitro permeation of bevacizumab through human sclera: effect of iontophoresis application, S. Pescina, G. Ferrari, P. Govoni, C. Macaluso, C. Padula, P. Santi, S. Nicoli, J. Pharm. Pharmacol., 2010
  • Single Layer Transdermal Film Containing Lidocaine: Water and Lidocaine Mobility Determined using Neutron Scattering, C. Padula, C. Chiapponi, M.T. Dibari, A. Deriu, F. Sonico, S. Barbieri, J. Ollivier, P. Santi, J. Pharm. Sci., 2010
  • Bioadhesive films containing benzocaine: correlation between in vitro permeation and in vivo local anesthetic effect, D. R. de Araujo, C. Padula, C. M. S. Cereda, G. R. Tófoli, R. Barbosa Brito Júnior, E. de Paula, S. Nicoli, P. Santi, Pharm. Res., 2010
  • Stratum corneum distribution of lidocaine in vivo from a new bioadhesive transdermal film, C. Padula, A. Fulgoni, P. Santi, Skin Res. and Technol., 16, 125-130 (2010).
  • Development and evaluation of occlusive systems employing polyvinyl alcohol for transdermal delivery of sumatriptan succinate, C. Balaguer-Fernández, C. Padula, A. Femenía-Font, V. Merino, P. Santi, A. López-Castellano, Drug Delivery, 17 (2), 83-91 (2010).
  • Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin, T. Senyigit, F. Sonvico, S. Barbieri, O. Ozer, P. Santi. P. Colombo, J. Control. Release, 142, 368-373 (2010).
  • Effect of lipopeptides and iontophoresis on acyclovir skin delivery, S. Nicoli, M. Eeman, M. Degeu, E. Bresciani, C. Padula, P. Santi, J. Pharm. Pharmacol., 62, 702-708 (2010)
  • Different approaches for improving skin accumulation of topical corticosteroids, T. Senyigit, C. Padula, O. Ozer, P. Santi, Int. J. Pharm., 380, 155-160 (2009)
  • In-vitro transcleral iontophoresis of high molecular weight neutral compounds, S. Nicoli, G. Ferrari, M. Quarta, C. Macaluso, P. Santi, Eur. J. Pharm. Sci., 36, 486-492 (2009).
  • Porcine sclera as a model for human sclera in in vitro transport experiments: histology, sem microscopy and comparative permeability, S. Nicoli, G. Ferrari, M. Quarta, C. Macaluso, P. Govoni, D. Dallatana, P. Santi, Molecular Vision, 15, 259-266 (2009).
  • Synthesis, hydrolysis and skin retention of aminoacid esters of a-tocopherol, F. Marra, C. Ostacolo, S. Laneri, A. Bernardi, A. Sacchi, C. Padula, S. Nicoli, P. Santi, J. Pharm. Sci., 98 (7), 2364-2376 (2009)
  • Innovative formulations for the delivery of levothyroxine to the skin, C. Padula, S. Nicoli, P. Santi, Int. J. Pharm., 372, 12-16 (2009).
  • Association of nicotinamide with parabens: effect on solubilità, partition and transdermal permeation, S. Nicoli, F. Zani, S. Bilzi, R. Bettini, P. Santi, Eur J. Pharm. Bipharm., 69, 613-621 (2008)
  • In vitro evaluation of the effect of electrotreatment on skin permeability, F. Marra, J.L. Levy, P. Santi, Y. Kalia, Journal of Cosmetic Dermatol., 7, 105-111 (2008)
  • Characterization of rabbit ear skin as a skin model for in vitro transdermal permeation experiments: histology, lipid composition and permeability, S. Nicoli, C. Padula, V. Aversa, B. Vietti, P.W. Wertz, A. Millet, F. Falson, P. Govoni, P. Santi, Skin Pharmacol. and Physiol, 21, 218-226 (2008)
  • Ethyl-paraben and nicotinamide mixtures: apparent solubility, thermal behaviour and X-ray structure of the 1:1 co-crystal, S. Nicoli, S. Bilzi, P. Santi, M.R. Caira, J. Li, R. Bettini, J. Pharm. Sci., 97 (11), 4830-4839 (2008).
  • Physical characterization of a new skin bioadhesive film, A. Nussinovitch, A. Gal, C. Padula, P. Santi, AAPS Pharm. Sci. Tech., 9 (2), 458-463 (2008).
  • Simultaneous determination of benzophenone-3, retinol and retinyl acetate in ear pig skin layers by high-performance liquid chromatography, C. Padula, N. Campana, P. Santi, Biomed Chromatog., 22, 1060-1065 (2008)
  • Transdermal Film Containing Nicotine and Bupropion for Combined Smoking Cessation Therapy, S. Nicoli, S. Cella, V. Aversa, P. Santi, Pharmaceutical Technology Europe, 20 (2), 22-29
  • Characterization of rabbit ear skin as a skin model for in vitro transdermal permeation experiments: histology, lipid composition and permeability, S. Nicoli, C. Padula, V. Aversa, B. Vietti, P.W. Wertz, A. Millet, F. Falson, P. Govoni, P. Santi, Skin Pharmacol. and Physiol, 21, 218-226 (2008)
  • In vitro evaluation of the effect of electrotreatment on skin permeability, F. Marra, J.L. Levy, P. Santi, Y. Kalia, Journal of Cosmetic Dermatol., 7, 105-111 (2008)
  • Association of nicotinamide with parabens: effect on solubilità, partition and transdermal permeation, S. Nicoli, F. Zani, S. Bilzi, R. Bettini, P. Santi, Eur J. Pharm. Bipharm., 69, 613-621 (2008)
  • In vitro permeation of levothyroxine across the skin, C. Padula, A. Pappani, P. Santi, Int. J. Pharm., 349, 161-165 (2008)
  • Influence of flow and packing properties on the pneumatic conveying of powdered mixtures for direct compression, C. D'Andria, G. Massimo, P.L. Catellani, P. Santi, R. Bettini, L. Bianco, P. Colombo, Pharm. Tech. Europe, 1, 17-23 (2000)
  • Response surface methodology applied to fluid bed granulation, P. Wherlé, P. Colombo, P. Santi, R. Bettini, F. Cudazzo, A. Nora, C. Tenore, P.L. Catellani, Pharm. Tech. Europe, 12 (4), 36-46 (2000)
  • Disintegration propensity of tablets evaluated by means of disintegrating force kinetics, G. Massimo, P.L. Catellani, P. Santi, R. Bettini, G.L. Vaona, A. Bonfanti, L. Maggi, P. Colombo, Pharm. Dev. and Technology, 5 (2), 163-169 (2000)
  • Dried sucralfate gel retaining the colloidal properties of sucralfate moist gel, L. Maggi, P.L. Catellani, E. Fisicaro, P. Santi, F. Zani, P. Colombo, AAPS PharmSciTech., 1 (3), art 28 (2000)
  • Distribution of khellin in excised human skin following iontophoresis and passive dermal transport, B. Marconi, F. Mancini, P. Colombo, F. Allegra, F. Giordano, A. Gazzaniga, G. Orecchia, P. Santi, J. Control. Release, 60 (2-3), 261-268 (1999)
  • Ionized prodrugs of dehydroepiandrosterone for transdermal iontophoretic delivery, S. Laneri, A. Sacchi, E. Abignente di Frassello, E. Luraschi, P. Colombo, P. Santi, Pharm. Res., 16 (12), 1818-1824 (1999)
  • Drug volume fraction profile in the gel phase and drug release kinetics in hydroxypropylmethil cellulose matrices containing a soluble drug, P. Colombo, R. Bettini, P.L. Catellani, P. Santi, N.A. Peppas, Eur. J. Pharm. Sci., 9 (1), 33-40 (1999)
  • Nicotine nasal powder: design and characterization, R. Bettini, C. D'Andria, P.L. Catellani, P. Santi, G. Massimo, P. Colombo, STP Pharma Sciences, 9 (5), 457-462 (1999)
  • In vitro acyclovir distribution in human skin layers after transdermal iontophoresis, N.M. Volpato, S. Nicoli, C. Laureri, P. Colombo, P. Santi, J. Control. Release, 50 (1-3), 291-296 (1998)
  • Partial permselective coating adds an osmotic contribution to drug release from swellable matrixes, P.L. Catellani, P. Colombo, N.A. Peppas, P. Santi, R. Bettini, J. Pharm. Sci., 87 (6), 726-731 (1998)
  • Drug reservoir composition and transport of salmon calcitonin in transdermal iontophoresis, P. Santi, P. Colombo, R. Bettini, P.L Catellani, A. Minutello, N.M. Volpato, Pharm. Res., 14 (1), 63-66 (1997)
  • Clean-In-Place System Evaluation of a Rotary Tabletting Machine, A. Bonfanti, P. Colombo, R. Trebbi, F. Cerveglieri, P. Santi, G. Massimo, P.L. Catellani, Pharmaceutical Technology Europe, 9 (4), 31-38 (1997).
  • Evaluation of preservative effectiveness in pharmaceutical products: the use of a wild strain of Pseudomonas cepacia, F. Zani, A. Minutello, L. Maggi, P. Santi, P. Mazza, J. Applied Bacteriology, 83 (3), 322-326 (1997)
  • Transdermal iontophoresis of salmon calcitonin can reproduce the hypocalcemic effect of intravenous administration, P. Santi, N.M. Volpato, R. Bettini, P.L. Catellani, G. Massimo, P. Colombo, Il Farmaco, 51 (6-7), 445-448 (1997)
  • Assay of acyclovir in human skin layers by high-performance liquid chromatography, N.M. Volpato, P. Santi, C. Laureri, P. Colombo, J. Chrom. Biomed. Appl., 16 (3), 515-520 (1997)
  • Reverse Iontophoresis - Parameters Determining Electroosmotic flow: I. pH and Ionic Strength, P. Santi and R.H. Guy, J. Contr. Release, 38, 159-165 (1996)
  • Delivery of nasal powders of ß-cyclodextrin by insufflation, A. De Ascentiis, R. Bettini, G. Caponetti, P.L. Catellani, M.T. Peracchia, P. Santi, P. Colombo, Pharm. Res., 13 (5), 734-738 (1996)
  • Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport, P. Colombo, R. Bettini, P. Santi, A. De Ascentiis, N.A. Peppas, J. Contr. Release, 39, 231-237 (1996)
  • Reverse Iontophoresis - Parameters Determining Electroosmotic flow: II. Electrode chamber formulation, P. Santi and R.H. Guy, J. Contr. Relesae,42, 29-36 (1996)
  • The suitability of a small scale high-shear mixer for powder pelletization, L. Maggi, A. Bonfanti, P. Santi, G. Massimo, P.L. Catellani, A. Bellotti, P. Colombo, A. Zanchetta, Pharm. Technol. Europe, 8 (9), 82-90 (1996)
  • Drug diffusion front movement is important in drug release control from swellable matrix tablets, P. Colombo, R. Bettini, G. Massimo, P.L. Catellani, P. Santi, N.A. Peppas, J. Pharm. Sci., 84 (8), 991-997 (1995)
  • Iontophoresis enhances the acyclovir transport through nude mouse skin by electrotransport and electroosmosis, N.M. Volpato, P. Santi, P. Colombo, Pharm. Res., 12 (11), 1623-1627 (1995)
  • The technology of pharmaceutical powders for nasal administration of drugs with systemic effect, A. De Ascentiis, P. Santi, P. Colombo, BCF International, 134 (0), 18-20 (1995)
  • Iontophoretic transport of verapamil and melatonin through hairless mouse skin, P. Santi, G. Massimo, P.L. Catellani, G. Morini, P. Colombo, Europ. J. Pharm. Sci., 1, 259-263 (1994)
  • Iontophoretic transport of verapamil and melatonin. I. Cellophane membranes as barrier, P. Santi, P.L. Catellani, G. Massimo, G. Zanardi, P. Colombo, Int. J. Pharm., 92, 23-28 (1993)
  • A comparative study of the disintegrating efficiency of polysaccharides in a directly tablettable formulation, C. Duru, P. Colombo, D. Gaudy, G. Massimo, P. Santi, P.L. Catellani, P. Barthelemy, Pharm. Technol. Int., 4 (5), 15-23 (1992)
  • The role of bond weakening by liquids in the disintegration of tablets, M. Luangtana-anan, P.L. Catellani, P. Colombo, R. Dinarvand, J.T. Fell, P. Santi, Eur. J. Pharm. Biopharm., 38 (5), 169-171 (1992)
  • Centrifugal die filling system in a new rotary tablet machine, P.L. Catellani, P. Santi, E. Gasperini, S. CIceri, G. Dondi, P. Colombo, Int. J. Pharm., 88, 285-291 (1992)
  • Permeation of piroxicam and piroxicam/ß-cyclodextrin inclusion compound through artificial membranes, R. Bettini, P. Santi, P.L. Catellani, G. Massimo, A. Bellotti, C. Barthélémy, A.-M. Guyot-Hermann, F. Trublin, P. Colombo, Eur. J. Pharm. Biopharm., 38 (6), 203-208 (1992)
  • Partition and transport of verapamil and nicotine through artificial membranes, P. Santi, P.L. Catellani, P. Colombo, C. Ringard-Lefebvre, C. Barthélémy and A.M. Guyot-Hermann, Int. J. Pharm., 68, 43-49 (1991)
  • Use of sucralfate humid gel in beauty masks formulation, D. Provasi, P. Colombo, G. Massimo, U. Conte, C. Caramella, P. Santi, Les Nouvelles Dermatologiques, 10 (1), 100-104 (1991)
  • Release mechanism of piroxicam from ß-cyclodextrin inclusion compound, P. Colombo, P. Santi, D. Provasi, A. De Ascentiis, G. Massimo, P.L. Catellani, Acta Technologiae et Legis Medicamenti, 2 (1), 37-49 (1991)
  • Piroxicam/ß-cyclodextrin inclusion compound ant its interaction with water, P.L. Catellani, P. Santi, M.G. Borazzo, A. Bellotti and P. Colombo, Minutes of 5th Intenational Symopsium on Cyclodextrins, Ed. D. Duchêne, Editions de Santé, Parigi (F) 445-449 (1990)
  • Alprenolol.HCl compressed matrices: discontinuous barrier for zero-order release rate, P. Santi, P. L. Catellani, A. Cassarà and P. Colombo, Chimica Oggi, 7 (4), 21-24 (1989)


Managed by Patrizia Santi - last update 2-07-2010